Medical Cannabis Market By Product Type (Dried Cannabis, Cannabis Oil, Capsules, Tinctures, Topicals {Creams, Lotions, Balms}, Edibles, Vaporizers), By Derivative (Cannabidiol (CBD), Tetrahydrocannabinol (THC), Balanced THC & CBD), By Application (Mental Health Disorders {Anxiety, Depression}, Neurological Disorders {Epilepsy, Alzheimer’s Disease, Parkinson's Disease}, Chronic Pain Management {Neuropathic Pain, Cancer, Inflammatory Pain}, Sleep Disorders, Other), By End-user (Pharmaceutical Industry, Research and Development Centres, Hospitals, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Medical Cannabis Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Growing acceptance of cannabis for medical use across global regions.

3.2.2. Increasing prevalence of chronic diseases boosting cannabis demand worldwide.

3.2.3. Rising investments in cannabis research and development for medical applications.

3.3. Key industry pitfalls & challenges

3.3.1. Stringent regulatory frameworks limiting medical cannabis market expansion globally.

3.3.2. Social stigma surrounding cannabis affecting its broader medical adoption.

3.3.3. Lack of standardized dosing and limited clinical evidence for efficacy.

3.4. Market Opportunities

3.4.1. Emerging markets legalizing cannabis for medical use driving growth opportunities.

3.4.2. Advancements in cannabis formulations offering targeted treatment solutions.

3.4.3. Partnerships between pharma companies and cannabis firms driving innovations.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Medical Cannabis Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Dried Cannabis

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Cannabis Oil

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Capsules

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Tinctures

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Topicals

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6.2. Creams

4.6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6.3. Lotions

4.6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6.4. Balms

4.6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.7. Edibles

4.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.8. Vaporizers

4.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Medical Cannabis Market, Derivative Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Derivative, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Cannabidiol (CBD)

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Tetrahydrocannabinol (THC)

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Balanced THC & CBD

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Medical Cannabis Market, Application Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Application, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Mental Health Disorders

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.2.2. Anxiety

6.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.2.3. Depression

6.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Neurological Disorders

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3.2. Epilepsy

6.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3.3. Alzheimer’s Disease

6.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3.4. Parkinson's Disease

6.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Chronic Pain Management

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4.2. Neuropathic Pain

6.4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4.3. Cancer

6.4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4.4. Inflammatory Pain

6.4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Sleep Disorders

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Other

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Medical Cannabis Market, End-user Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-user, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Pharmaceutical Industry

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Research and Development Centres

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Hospitals

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Others

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Medical Cannabis Market, Region Segment Analysis

8.1. Overview

8.1.1. Global Market Revenue Share, By Region, 2025 & 2035

8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)

8.2.2. North America Market Revenue, By Product Type, 2025-2035

8.2.3. North America Market Revenue, By Derivative, 2025-2035

8.2.4. North America Market Revenue, By Application, 2025-2035

8.2.5. North America Market Revenue, By End-user, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Product Type, 2025-2035

8.2.6.2. U.S. Market Revenue, By Derivative, 2025-2035

8.2.6.3. U.S. Market Revenue, By Application, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-user, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Product Type, 2025-2035

8.2.7.2. Canada Market Revenue, By Derivative, 2025-2035

8.2.7.3. Canada Market Revenue, By Application, 2025-2035

8.2.7.4. Canada Market Revenue, By End-user, 2025-2035

8.3. Europe

8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)

8.3.2. Europe Market Revenue, By Product Type, 2025-2035

8.3.3. Europe Market Revenue, By Derivative, 2025-2035

8.3.4. Europe Market Revenue, By Application, 2025-2035

8.3.5. Europe Market Revenue, By End-user, 2025-2035

8.3.6. Germany

8.3.6.1. Germany Market Revenue, By Product Type, 2025-2035

8.3.6.2. Germany Market Revenue, By Derivative, 2025-2035

8.3.6.3. Germany Market Revenue, By Application, 2025-2035

8.3.6.4. Germany Market Revenue, By End-user, 2025-2035

8.3.7. France

8.3.7.1. France Market Revenue, By Product Type, 2025-2035

8.3.7.2. France Market Revenue, By Derivative, 2025-2035

8.3.7.3. France Market Revenue, By Application, 2025-2035

8.3.7.4. France Market Revenue, By End-user, 2025-2035

8.3.8. U.K.

8.3.8.1. U.K. Market Revenue, By Product Type, 2025-2035

8.3.8.2. U.K. Market Revenue, By Derivative, 2025-2035

8.3.8.3. U.K. Market Revenue, By Application, 2025-2035

8.3.8.4. U.K. Market Revenue, By End-user, 2025-2035

8.3.9. Italy

8.3.9.1. Italy Market Revenue, By Product Type, 2025-2035

8.3.9.2. Italy Market Revenue, By Derivative, 2025-2035

8.3.9.3. Italy Market Revenue, By Application, 2025-2035

8.3.9.4. Italy Market Revenue, By End-user, 2025-2035

8.3.10. Spain

8.3.10.1. Spain Market Revenue, By Product Type, 2025-2035

8.3.10.2. Spain Market Revenue, By Derivative, 2025-2035

8.3.10.3. Spain Market Revenue, By Application, 2025-2035

8.3.10.4. Spain Market Revenue, By End-user, 2025-2035

8.3.11. Rest of Europe

8.3.11.1. Rest of Europe Market Revenue, By Product Type, 2025-2035

8.3.11.2. Rest of Europe Market Revenue, By Derivative, 2025-2035

8.3.11.3. Rest of Europe Market Revenue, By Application, 2025-2035

8.3.11.4. Rest of Europe Market Revenue, By End-user, 2025-2035

8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)

8.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

8.4.3. Asia Pacific Market Revenue, By Derivative, 2025-2035

8.4.4. Asia Pacific Market Revenue, By Application, 2025-2035

8.4.5. Asia Pacific Market Revenue, By End-user, 2025-2035

8.4.6. China

8.4.6.1. China Market Revenue, By Product Type, 2025-2035

8.4.6.2. China Market Revenue, By Derivative, 2025-2035

8.4.6.3. China Market Revenue, By Application, 2025-2035

8.4.6.4. China Market Revenue, By End-user, 2025-2035

8.4.7. Japan

8.4.7.1. Japan Market Revenue, By Product Type, 2025-2035

8.4.7.2. Japan Market Revenue, By Derivative, 2025-2035

8.4.7.3. Japan Market Revenue, By Application, 2025-2035

8.4.7.4. Japan Market Revenue, By End-user, 2025-2035

8.4.8. India

8.4.8.1. India Market Revenue, By Product Type, 2025-2035

8.4.8.2. India Market Revenue, By Derivative, 2025-2035

8.4.8.3. India Market Revenue, By Application, 2025-2035

8.4.8.4. India Market Revenue, By End-user, 2025-2035

8.4.9. Australia

8.4.9.1. Australia Market Revenue, By Product Type, 2025-2035

8.4.9.2. Australia Market Revenue, By Derivative, 2025-2035

8.4.9.3. Australia Market Revenue, By Application, 2025-2035

8.4.9.4. Australia Market Revenue, By End-user, 2025-2035

8.4.10. South Korea

8.4.10.1. South Korea Market Revenue, By Product Type, 2025-2035

8.4.10.2. South Korea Market Revenue, By Derivative, 2025-2035

8.4.10.3. South Korea Market Revenue, By Application, 2025-2035

8.4.10.4. South Korea Market Revenue, By End-user, 2025-2035

8.4.11. Singapore

8.4.11.1. Singapore Market Revenue, By Product Type, 2025-2035

8.4.11.2. Singapore Market Revenue, By Derivative, 2025-2035

8.4.11.3. Singapore Market Revenue, By Application, 2025-2035

8.4.11.4. Singapore Market Revenue, By End-user, 2025-2035

8.4.12. Rest of Asia Pacific

8.4.12.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

8.4.12.2. Rest of Asia Pacific Market Revenue, By Derivative, 2025-2035

8.4.12.3. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

8.4.12.4. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

8.5. Latin America

8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)

8.5.2. Latin America Market Revenue, By Product Type, 2025-2035

8.5.3. Latin America Market Revenue, By Derivative, 2025-2035

8.5.4. Latin America Market Revenue, By Application, 2025-2035

8.5.5. Latin America Market Revenue, By End-user, 2025-2035

8.5.6. Brazil

8.5.6.1. Brazil Market Revenue, By Product Type, 2025-2035

8.5.6.2. Brazil Market Revenue, By Derivative, 2025-2035

8.5.6.3. Brazil Market Revenue, By Application, 2025-2035

8.5.6.4. Brazil Market Revenue, By End-user, 2025-2035

8.5.7. Argentina

8.5.7.1. Argentina Market Revenue, By Product Type, 2025-2035

8.5.7.2. Argentina Market Revenue, By Derivative, 2025-2035

8.5.7.3. Argentina Market Revenue, By Application, 2025-2035

8.5.7.4. Argentina Market Revenue, By End-user, 2025-2035

8.5.8. Mexico

8.5.8.1. Mexico Market Revenue, By Product Type, 2025-2035

8.5.8.2. Mexico Market Revenue, By Derivative, 2025-2035

8.5.8.3. Mexico Market Revenue, By Application, 2025-2035

8.5.8.4. Mexico Market Revenue, By End-user, 2025-2035

8.5.9. Rest of Latin America

8.5.9.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

8.5.9.2. Rest of Latin America Market Revenue, By Derivative, 2025-2035

8.5.9.3. Rest of Latin America Market Revenue, By Application, 2025-2035

8.5.9.4. Rest of Latin America Market Revenue, By End-user, 2025-2035

8.6. MEA

8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)

8.6.2. MEA Market Revenue, By Product Type, 2025-2035

8.6.3. MEA Market Revenue, By Derivative, 2025-2035

8.6.4. MEA Market Revenue, By Application, 2025-2035

8.6.5. MEA Market Revenue, By End-user, 2025-2035

8.6.6. GCC Countries

8.6.6.1. GCC Countries Market Revenue, By Product Type, 2025-2035

8.6.6.2. GCC Countries Market Revenue, By Derivative, 2025-2035

8.6.6.3. GCC Countries Market Revenue, By Application, 2025-2035

8.6.6.4. GCC Countries Market Revenue, By End-user, 2025-2035

8.6.7. South Africa

8.6.7.1. South Africa Market Revenue, By Product Type, 2025-2035

8.6.7.2. South Africa Market Revenue, By Derivative, 2025-2035

8.6.7.3. South Africa Market Revenue, By Application, 2025-2035

8.6.7.4. South Africa Market Revenue, By End-user, 2025-2035

8.6.8. Rest of Middle-East & Africa

8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035

8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Derivative, 2025-2035

8.6.8.3. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

8.6.8.4. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

9. Company Profile

9.1. Canopy Growth Corporation

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. Aurora Cannabis Inc.

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. Tilray, Inc.

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. GW Pharmaceuticals

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. Cronos Group Inc.

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. Aphria Inc.

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. Curaleaf Holdings, Inc.

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. Trulieve Cannabis Corp.

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Green Thumb Industries

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. MedMen Enterprises Inc.

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Product/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. Charlotte's Web Holdings, Inc.

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Product/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. Cresco Labs Inc.

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Product/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. Aleafia Health Inc.

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Product/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. Hexo Corp.

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Product/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. Harvest Health & Recreation Inc.

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Product/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis

9.16. TerrAscend Corp.

9.16.1. Business Overview

9.16.2. Financial Performance

9.16.3. Product/Service Offerings

9.16.4. Strategies & recent developments

9.16.5. SWOT Analysis

9.17. Columbia Care Inc.

9.17.1. Business Overview

9.17.2. Financial Performance

9.17.3. Product/Service Offerings

9.17.4. Strategies & recent developments

9.17.5. SWOT Analysis

9.18. Organigram Holdings Inc.

9.18.1. Business Overview

9.18.2. Financial Performance

9.18.3. Product/Service Offerings

9.18.4. Strategies & recent developments

9.18.5. SWOT Analysis